January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Novo Nordisk (NVO) shares surged after the company reported breakthrough weight-loss drug trial results. The pharmaceutical company's injectable GLP-1 Amycretin medication demonstrated an ...

Shares in Google-parent Alphabet (GOOGL, GOOG) tumbled in after-hours trading following the release of the tech giant's ...

European stock indices opened mixed on Wednesday amid a slew of corporate earnings, while investors are still trying to figure out what a trade war means and whether it will even happen. The FTSE 100 ...

Compounding the disappointment around Alphabet's numbers was its key cloud computing division. Revenue at the business ...

Beijing made sure it acted before that ... Danish weight-loss drug manufacturer Novo Nordisk reports the week after. European stocks attracted their second largest allocation in a quarter of a century ...

In a week that started with U.S. President Donald Trump kicking off a trade war and whipping up market volatility ...

Global stocks steadied on Friday ahead of key U.S. payrolls data, with investors cautiously optimistic that the world might avoid a full-on trade war, while the ...

This week, critical economic events include the U.S. Federal Reserve, European Central Bank, and Bank of Canada's first 2025 ...

SINGAPORE/NEW YORK - Global shares rose on Thursday in a modest relief rally as fears of an escalating trade war between the U.S. and its major trading partners ebbed, while U.S. Treasury yields came ...